MedPath
NMPA Approval

Esketamine Hydrochloride Injection

国药准字H20247040

March 5, 2024

国药准字H20193336

Drug Information

盐酸艾司氯胺酮注射液

注射剂

5ml:25mg(按C₁₃H₁₆ClNO计)

化学药品

March 5, 2024

Company Information

Applicant Company

连云港经济技术开发区黄河路38号

Manufacturing Company

连云港经济技术开发区临港产业区东晋路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸艾司氯胺酮注射液 - NMPA 批准文号 | MedPath